Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rakovina Therapeutics Inc (RKV.VN)

Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rakovina Therapeutics Inc 105 1008 Beach Avenue Vancouver BC V6E 1T7 CAN

https://www.rakovinatherapeutics.com P: 604-619-0225 F: 604-980-6264

Sector:

Medical

Description:

Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and optimize drug candidates at a much greater pace than ever before. The company has established a pipeline of distinctive DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners.

Key Statistics

Overview:

Market Capitalization, $K 3,066
Shares Outstanding, K 21,148

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -4,073 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,782 K

Growth:

1-Year Return -91.67%
3-Year Return -90.94%
5-Year Return 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 11/28/25
Next Earnings Date N/A
Earnings Per Share ttm -0.56
EPS Growth vs. Prev Year 65.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 06/24/25

RKV.VN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -333.54%
Return-on-Assets % -156.50%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book 1.62
Book Value/Share 0.09
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar